Publication | Open Access

Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination

Neuro-oncologyGliomaLarge GroupMedicineImmunologyVaccine TrialTherapeutic VaccineHgg-immuno Rpa ModelHigh-grade GliomasRelapsed Malignant GliomaImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentCancer Research